Literature DB >> 33378566

Outcomes and prognostic factors in 70 non-survivors and 595 survivors with COVID-19 in Wuhan, China.

Mingyu Liu1, Shuolong Han2, Qiaohong Liao3, Liping Chang2, Yunzhe Tan1, Pingping Jia3, Libo Yang2, Hongbin Cai1, Shaolun Feng3, Can Chen3, Shi Zhang3, Zhenhua Jia2,4, Jian Yi1.   

Abstract

Since first outbreak of coronavirus disease 2019 (COVID-19) occurred in December 2019, more than 51 millions cases had been reported globally. We aimed to identify the risk factors for in-hospital fatal outcome and severe pneumonia of this disease.This is a retrospective, multicentre study, which included all confirmed cases of COVID-19 with definite outcomes (died or discharged) hospitalized between January 1st and March 4th 2020 in Wuhan. Of all 665 patients included: 70 died, 595 discharged (including 333 mild and 262 severe cases). Underlying comorbidity was more commonly observed among deaths (72.9%) than mild (26.4%) and severe (61.5%) survivors, with hypertension, diabetes and cardiovascular as dominant diseases. Fever and cough were the primary clinical magnifications. Older age (≥ 65 years) (OR=3.174, 95% CI=1.356-7.755), diabetes (OR=2.540, 95% CI=0.995-6.377), dyspnea (OR=7.478, 95% CI=3.031-19.528), respiratory failure (OR=10.528, 95% CI= 4.484-25.829), acute cardiac injury (OR=25.103, 95% CI=9.057-76.590), and acute respiratory distress syndrome (OR=7.308, 95% CI=1.501-46.348) were associated with in-hospital fatal outcome. In addition, older age (OR=2.149, 95% CI=1.424-3.248), diabetes (OR=3.951, 95% CI=2.077-7.788), cardiovascular disease (OR=3.414, 95% CI=1.432-8.799), nervous system disease (OR=4.125, 95% CI=1.252-18.681), dyspnea (OR=31.944, 95% CI=18.877-92.741), achieving highest in-hospital temperature of >39.0℃ (OR=37.450, 95% CI=7.402-683.403), and longer onset of illness to diagnosis (≥ 9 days) were statistically associated with higher risk of developing severe COVID-19. In conclusion, the potential risk factors of older age, diabetes, dyspnea, respiratory failure, acute cardiac injury and acute respiratory distress syndrome could help clinicians to identify patients with poor prognosis at an early stage. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  2019 novel coronavirus; acute respiratory disease; fatality; prognosis

Year:  2020        PMID: 33378566     DOI: 10.1111/tbed.13969

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  2 in total

1.  Isolation and characterization of mammalian orthoreovirus type 3 from a fecal sample from a wild boar in Japan.

Authors:  Wenjing Zhang; Michiyo Kataoka; Yen Hai Doan; Toru Oi; Tetsuya Furuya; Mami Oba; Tetsuya Mizutani; Tomoichiro Oka; Tian-Cheng Li; Makoto Nagai
Journal:  Arch Virol       Date:  2021-04-11       Impact factor: 2.574

2.  Surveillance of Class I Newcastle Disease Virus at Live Bird Markets and Commercial Poultry Farms in Eastern China Reveals the Epidemic Characteristics.

Authors:  Xiaolong Lu; Xiaoquan Wang; Tiansong Zhan; Yifan Sun; Xin Wang; Naiqing Xu; Tianxing Liao; Yu Chen; Min Gu; Shunlin Hu; Xiaowen Liu; Xiufan Liu
Journal:  Virol Sin       Date:  2021-03-15       Impact factor: 4.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.